Skip to content
FLFunding Landscape
Open·Ingested 90 days ago, not re-verified since

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)
Posted
May 4, 2026
Amount
$10,080,000
Closes
Sep 30, 2026 (in 58 days)

Get alerted when new grant funding like this opens.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526ALSRPTIA
Assistance listing (CFDA)
12.420

Amount

$10,080,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.

Related opportunities

Refine this search